Spikevax XFG
0.1 mg/mL dispersion for injection in multi-dose vial
50 micrograms dispersion for injection in pre-filled syringe
Approved indication
• Multi-dose vial: Active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older.
• Pre-filled syringe: Active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 12 years of age and older.